Kestra Medical (KMTS) insider files to sell 7,590 common shares

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. (KMTS) has a selling securityholder, Traci Umberger, filing to sell common stock under Rule 144. The planned transaction lists 7,590 shares of common stock to be sold through Merrill Lynch on or after 08/03/2026, with an indicated value of $181,061.84 on NASDAQ.

The shares relate to a 07/17/2026 vesting of performance share unit awards granted as part of issuer equity compensation. Over the prior three months, Umberger sold 5,887 shares for $133,892.22 on 07/30/2026 and 8,752 shares for $197,837.19 on 07/31/2026.

Key Figures

Planned shares to be sold: 7,590 shares Planned sale value: $181,061.84 Shares sold 07/30/2026: 5,887 shares +4 more

7 metrics

Planned shares to be sold 7,590 shares Common stock to be sold through Merrill Lynch on or after 08/03/2026

Planned sale value $181,061.84 Indicated value of 7,590 KMTS common shares to be sold on NASDAQ

Shares sold 07/30/2026 5,887 shares KMTS common stock sold by Traci Umberger on 07/30/2026

Value sold 07/30/2026 $133,892.22 Proceeds from 5,887 KMTS shares sold on 07/30/2026

Shares sold 07/31/2026 8,752 shares KMTS common stock sold by Traci Umberger on 07/31/2026

Value sold 07/31/2026 $197,837.19 Proceeds from 8,752 KMTS shares sold on 07/31/2026

PSU vesting date 07/17/2026 Vesting of performance share unit awards tied to equity compensation

Key Terms

performance share unit awards, equity compensation, Common Stock

3 terms

performance share unit awards financial

"Common Stock | 07/17/2026 | Vesting of performance share unit awards"

equity compensation financial

"Granted as part of issuer equity compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Common Stock financial

"Common Stock | 07/30/2026 | 5887 | 133892.22"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:42 PM Accepted by SEC EDGAR 08/03/2026 - 04:41 PM Learn about SEC filing dates

FAQ

What does Kestra Medical Technologies (KMTS) report in this Form 144?

Kestra Medical Technologies (KMTS) reports that Traci Umberger intends to sell 7,590 shares of KMTS common stock under Rule 144, following recent equity compensation vesting and prior stock sales in late July 2026.

How many KMTS shares is the insider planning to sell under this filing?

The insider plans to sell 7,590 shares of KMTS common stock. The planned sale has an indicated value of $181,061.84 and is to be executed through Merrill Lynch on or after 08/03/2026 on NASDAQ.

What recent KMTS stock sales has Traci Umberger reported?

Traci Umberger reported selling 5,887 shares for $133,892.22 on 07/30/2026 and 8,752 shares for $197,837.19 on 07/31/2026. These transactions involve KMTS common stock and are disclosed as sales during the past three months.

What is the source of the KMTS shares being sold by Traci Umberger?

The KMTS shares are tied to the vesting of performance share unit awards on 07/17/2026. These awards were granted as part of issuer equity compensation, meaning they arose from Kestra Medical Technologies’ compensation programs.

Which broker and market are involved in the planned KMTS share sale?

The planned sale of 7,590 KMTS shares will be executed through Merrill Lynch at 225 Liberty Street, New York. The shares are listed for trading on NASDAQ, where the Rule 144 transactions are expected to occur.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	7590	181061.84	58602497	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Vesting of performance share unit awards	KESTRA MEDICAL TECHNOLOGIES, LTD.			7590	07/17/2026	Granted as part of issuer equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Traci Umberger 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/30/2026	5887	133892.22
Traci Umberger 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/31/2026	8752	197837.19

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)